Literature DB >> 17467467

Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery.

Andreas Koster1, Thomas Hentschel, Tom Groman, Hermann Kuppe, Roland Hetzer, Sebastian Harder, Karl-Georg Fischer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17467467     DOI： 10.1016/j.jtcvs.2007.01.008

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  4 in total

1.  Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.

Authors:  Duane Bates; Sarah Griffin; Barb Angel
Journal:  Can J Hosp Pharm       Date:  2009-07

Review 2.  Direct thrombin inhibitors: pharmacology and application in intensive care medicine.

Authors:  Eva Schaden; Sibylle A Kozek-Langenecker
Journal:  Intensive Care Med       Date:  2010-04-28       Impact factor: 17.440

Review 3.  Argatroban in the management of heparin-induced thrombocytopenia.

Authors:  Luciano Babuin; Vittorio Pengo
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

Review 4.  Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Authors:  Marcie J Hursting; Joseph Soffer
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.